It is the second drug in the PD-1/PD-L1 inhibitor class to be cleared in a subcutaneous injection form by the FDA after Roche's Tecentriq Hybreza (atezolizumab and hyaluronidase) – which got a ...
Othman T, Frankel P, Allen P, et al. Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma. Haematologica . 2025;110(1):142 ...
NICE is unable to make a recommendation about the use in the NHS of atezolizumab for untreated advanced or recurrent non-small-cell lung cancer when platinum-doublet chemotherapy is unsuitable in ...
Patients with HCC at high risk of recurrence after resection or local ablation were randomly assigned to receive either atezolizumab plus bevacizumab or active surveillance in the IMbrave 050 study.
Studies examining the effect of marijuana smoking on lung function have produced somewhat variable results. This is likely to be related to the difficulty in obtaining random samples of smokers ...
The California Technology Assessment Forum is requested to review the scientific evidence for the use of low dose spiral computerized tomography (LDCT) as a modality for lung cancer screening ...
On February 13, Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative allogeneic chimeric antigen receptor (CAR) T-cell therapy ...
The subcutaneous version is a co-formulation of pembrolizumab and berahyaluronidase alfa, a hyaluronidase enzyme developed by Alteogen. The enzyme temporarily hydrolyses hyaluronan in the ...
Pancreatic cancer is one of the deadliest cancers. But those battling the disease saw promising results in the small clinical trial of an mRNA vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback